• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多发性骨髓瘤诊断期间骨髓组织学检查的选择]

[Options for histological examination of bone marrow during diagnosis of multiple myeloma].

作者信息

Fabian P, Moulis M

机构信息

Oddelení onkologické a experimentální patologie Masarykova onkologického ústavu Brno.

出版信息

Vnitr Lek. 2006 Nov;52 Suppl 2:66-70.

PMID:18175431
Abstract

The quantification of plasma cells in bone marrow is an essential step in plasma cell dyscrasia diagnostics. Besides cytological examination of bone marrow aspirates, plasma cells can also be quantified by histological examination of samples obtained by sternal puncture or trephine biopsy. Acquired bone marrow particles dispersed in aspirated marrow blood are usually sufficient for microscopic diagnosis. Histological examination offers, in comparison with cytology alone, several advantages. In this method, the number of plasmacytes is not distorted by their dilution by peripheral blood cells. Acquired material can be stored for a long time without showing any changes and it allows multiple re-use for purposes of prospective determination of other parameters. Plasmacyte count in histological sections is difficult and laborious and is not a routine practice. A qualified estimate ofplasmacyte percentage allows classification into the none/small/big criterion categories according to the WHO diagnostic scheme. Cell count using digital imaging is also possible, even using software image analysis, but this method requires a digital camera coupled with a microscope. Besides elementary plasmacyte count, it is also possible to determine their mono- or polyclonality. This reaction has certain technical pitfalls and its evaluation is sometimes impossible. Determination of some antigens' expression has prognostic (Ki67 index), predictive (CD56) or therapeutic (CD20, CD40, CD74, etc) significance. Histological material can also be used for interphase fluorescent in situ hybridisation.

摘要

骨髓中浆细胞的定量是浆细胞异常增生性疾病诊断的关键步骤。除了对骨髓穿刺液进行细胞学检查外,还可通过对胸骨穿刺或环钻活检获取的样本进行组织学检查来定量浆细胞。分散在抽取的骨髓血中的获得性骨髓颗粒通常足以进行显微镜诊断。与单纯的细胞学检查相比,组织学检查具有多个优点。在这种方法中,浆细胞数量不会因被外周血细胞稀释而失真。获取的材料可以长时间保存而不发生任何变化,并且可以多次重复使用,以便前瞻性地确定其他参数。组织学切片中的浆细胞计数困难且费力,并非常规操作。根据世界卫生组织的诊断方案,对浆细胞百分比进行合格评估可将其分为无/小/大标准类别。使用数字成像甚至软件图像分析进行细胞计数也是可行的,但这种方法需要将数码相机与显微镜结合使用。除了基本的浆细胞计数外,还可以确定它们的单克隆性或多克隆性。这种反应存在一定的技术缺陷,有时无法进行评估。某些抗原表达的测定具有预后(Ki67指数)、预测(CD56)或治疗(CD20、CD40、CD74等)意义。组织学材料也可用于间期荧光原位杂交。

相似文献

1
[Options for histological examination of bone marrow during diagnosis of multiple myeloma].[多发性骨髓瘤诊断期间骨髓组织学检查的选择]
Vnitr Lek. 2006 Nov;52 Suppl 2:66-70.
2
[Diagnostic importance and pitfalls of evaluating bone marrow smear preparation in multiple myeloma].[多发性骨髓瘤骨髓涂片制备评估的诊断重要性及陷阱]
Vnitr Lek. 2006 Nov;52 Suppl 2:55-65.
3
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.骨髓活检标本的CD138免疫染色对量化MGUS和骨髓瘤中的骨髓受累情况的敏感性,包括浆细胞比例低的样本。
Haematologica. 2006 Jul;91(7):972-5.
4
Bone marrow evaluation: the relative merits of particle sections and smear preparations.骨髓评估:颗粒切片与涂片制备的相对优点
Appl Pathol. 1983;1(4):181-93.
5
Histomorphology of multiple myeloma on bone marrow biopsy.骨髓活检中多发性骨髓瘤的组织形态学
Indian J Pathol Microbiol. 2004 Jul;47(3):359-63.
6
[Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications].
Sangre (Barc). 1989 Aug;34(4):313-4.
7
Bone marrow biopsy in multiple myeloma: a clinical pathological study.多发性骨髓瘤的骨髓活检:一项临床病理研究
Isr J Med Sci. 1988 Jun;24(6):298-301.
8
Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.骨髓活检联合免疫组织化学在骨髓瘤患者随访中优于骨髓穿刺。
J Clin Pathol. 2008 Feb;61(2):213-6. doi: 10.1136/jcp.2007.049130. Epub 2007 May 25.
9
Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.多发性骨髓瘤骨髓穿刺及活检组织病理检查的审计——一项单中心研究
Clin Lab Haematol. 2004 Dec;26(6):403-6. doi: 10.1111/j.1365-2257.2004.00646.x.
10
Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.多发性骨髓瘤的初始骨髓检查结果。浆细胞结节的意义。
Arch Pathol Lab Med. 1986 Jan;110(1):30-3.

引用本文的文献

1
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors.新诊断多发性骨髓瘤患者的全血黏度及白蛋白/纤维蛋白原比值计算:与部分预后预测指标的关系
Biomedicines. 2023 Mar 21;11(3):964. doi: 10.3390/biomedicines11030964.
2
Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.骨髓穿刺和活检的联合评估对多发性骨髓瘤的预后具有优越性。
Diagn Pathol. 2010 May 18;5:30. doi: 10.1186/1746-1596-5-30.